BNGO
Q4 2026 EPS Estimate
$-0.45
Nov 12, 2026 · Reports after close
Revenue Estimate
$8M
FY2030E EPS$0.20

Analyst Sentiment

Wall St. Consensus
Buy
6 analysts·Limited coverage
67
Score
4 Buy (67%)2 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
467%
Hold
233%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$1.00
-18.7%
Consensus
$5.00
+306.5%
Bull
$175.00
+14127.6%
12-Month Target Range6 analysts
$1.00$5.00$175.00
Current $1.23Consensus
Current Price
$1.23
Upside to Consensus
$3.77

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+33.34%
EPS
FY2028
Rev+26.55%
EPS
FY2029
Rev+21.39%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$32M$43M$55M$67M$81M
Low$32M$43M$55M$66M$80M
High$33M$43M$55M$67M$81M
EBITDA Avg$-30M$-40M$-50M$-61M$-74M
Low$-30M$-40M$-50M$-61M$-74M
High$-30M$-39M$-50M$-61M$-74M
EBIT Avg$-32M$-43M$-54M$-65M$-79M
Low$-32M$-43M$-54M$-66M$-80M
High$-32M$-42M$-54M$-65M$-79M
Net Income Avg$-12M$-5M$-3M$-1M$1M
Low$-12M$-5M$-3M$-1M$1M
High$-12M$-5M$-3M$-1M$1M
EPS Avg$-2.13$-0.97$-0.52$-0.24$0.20
Low$-2.14$-0.97$-0.52$-0.24$0.20
High$-2.12$-0.97$-0.52$-0.24$0.20
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$9M$9M$9M$10M$12M$13M$12M$13M
Low$9M$9M$9M$10M$12M$13M$12M$13M
High$9M$9M$9M$10M$12M$13M$13M$13M
EBITDA Avg$-8M$-9M$-8M$-9M$-11M$-12M$-11M$-12M
Low$-8M$-9M$-8M$-9M$-11M$-12M$-11M$-12M
High$-8M$-9M$-8M$-9M$-11M$-12M$-11M$-12M
EBIT Avg$-9M$-9M$-9M$-10M$-11M$-12M$-12M$-13M
Low$-9M$-9M$-9M$-10M$-12M$-13M$-12M$-13M
High$-9M$-9M$-9M$-10M$-11M$-12M$-12M$-13M
Net Income Avg$-5M$-5M
Low$-5M$-5M
High$-5M$-5M
EPS Avg$-0.42$-0.40
Low$-0.42$-0.40
High$-0.42$-0.40
Analysts (Rev / EPS)1 / 12 / 11 / 1 / 1 / 1 / 1 / 1 /

Earnings Surprises

Recent Analyst Actions

May 20, 2025Maxim Group
Bionano Genomics upgraded to Buy from Hold at Maxim
Target:$8.00
+112.2%from $3.77
Aug 28, 2024Scotiabank
Bionano Genomics downgraded at Scotiabank on limited capital market visibility
Target:$1.00
+95.1%from $0.51
May 16, 2024BTIG
Bionano Genomics (BNGO) PT Lowered to $2 at BTIG
Target:$2.00
+73.9%from $1.15
May 25, 2023EF Hutton
Bionano Genomics' Next-Gen Platform Set to Boost Throughput by 13x: Future of Cytogenetic Analysis Underway
Target:$1.75
-97.3%from $65.00
Dec 12, 2022BTIG
BTIG Assumes Bionano Genomics at Buy, Announces Price Target of $3.5
Target:$3.50
-98.4%from $219.00
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.